Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of MEDI0382 in Japanese preobese or obese adults with type 2 diabetes
jRCT2080224025Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Aug 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cotadutide in type 2 diabetes mellitus (T2DM) and obesity (4 arms), sponsored by AstraZeneca. Started Aug 2018; status: completed.
02
Drugs
cotadutide
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on jRCT2080224025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224025.